Dr. Jane L Lynch MD
School of Medicine
Pediatrics
University of Texas Health Science Center at San Antonio
MedicalResearch.com: What are the main findings of the study?
Dr. Lynch: American youth with type 2 diabetes who received the best currently available treatment and close monitoring of their diabetes experienced a more rapid progression of co-morbidities far more aggressive than what is typically seen in adults with type 2 diabetes.
MedicalResearch.com: Were any of the findings unexpected?
Dr. Lynch: Youth with type 2 diabetes enrolled in the TODAY study developed early and rapidly progressing signs of heart and kidney disease, poor glycemic control and diabetes-related eye disease; even in the group receiving more intensive two-drug therapy, shown in previously released results to be the most effective treatment for maintenance of glycemic control.
John D. Mathews, MBBS, MD, PhD, DSc Hon, DMedSc Hon,
Professor of epidemiology at the School of Population and Global Health,
University of Melbourne,
Carlton, Victoria, Australia
Cancer risk in 680 000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians
MedicalResearch.com: What are the main findings of the study?
Prof Mathews: We found that for persons having at least one CT scan before the age of 20 years, and followed for an average period of 10 years, the average risk of cancer was increased by 24% compared with unexposed persons matched for age, sex and year of birth. The cancer risk increased by 16% for each CT scan that preceded the cancer by more than one year. The proportional increase in risk was greater for persons exposed at younger ages.
MedicalResearch.com eInterview with Muhammad Mamdani Director, Applied Health Research Centre, St. Michael's Hospital Scientist in the Keenan Research Centre of the Li Ka Shing Knowledge Institute of St. Michael's Hospital Associate Professor, Department of Health Policy, Management, and Evaluation University of Toronto MedicalResearch.com: What are the main findings of this study? Our study examined over 470,000...
MedicalResearch.com eInterview with Dr. Giuseppe Orlando, M.D., Ph.D.
Dr. William A. Bauman, MD
Veterans Affairs Rehabilitation Research and Development
National Center of Excellence for the Medical Consequences of Spinal Cord Injury
Suite 7A-13, James J. Peters Veterans Affairs Medical Center
130 West Kingsbridge Road, Bronx, NY 10468;
MedicalResearch.com: What are the main findings of the study?
Dr. Bauman: In a prospective, randomized two-group, double-blind, placebo-controlled, intention-to-treat clinical trial, we determined whether SCI in-patients with a full thickness (Stage III or IV) pressure ulcers of the pelvic region who received 24 weeks or less of optimized clinical care and an oral anabolic steroid agent, oxandrolone, have a greater percent of healed target pressure ulcers than those who received placebo and the same clinical care. There was no significant difference in proportion of pressure ulcers that healed between the treatment and placebo groups [treatment recipients 24.1% (95% CI, 16.0% to 32.1%) and placebo recipients 29.8% (CI, 21% to 38.6%) with a difference, -5.7 percentage points (CI, -17.5 to 6.8 percentage points)]. Also, the rate of healing of wounds at 28 days was not significantly different between the groups (50.9% of the oxandrolone group and 43.3% of the placebo group had healing of ≥30.0%), nor was the number of wounds that remained closed at 8 weeks significantly different (16.7% of the oxandrolone group and 15.4% of the placebo group). No serious adverse events were related to drug administration but a significantly greater proportion of patients had elevated liver enzymes in the treatment group [treatment recipients 32.4% (95% CI, 23.6% to 41.2%) and placebo recipients 2.9%% (CI, 0.0% to 6.1%).
Thus, oxandrolone showed no benefit over placebo for improving healing of chronic pressure ulcers of the pelvic region or the proportion that remained closed after 8 weeks of treatment.
MedicalResearch.com eInterview with Luis Beck-da-Silva, MD, ScD Cardiology Division, Heart Failure Clinic Hospital de Clínicas de Porto Alegre Rua Ramiro Barcelos, 2350 Sala 2060 Porto Alegre, RS 90035-903, Brazil MedicalResearch.com: What are the main findings of the study? Answer: The actual take home message is that fluid and sodium restriction may not be of any benefit...
MedicalResearch.com eInterview with: Christopher J Lindsell, PhD Vice Chair for Research, Department of Emergency Medicine Director of Biostatistics, Epidemiology and Research Design, Center for Clinical and Translational Science and Training University of Cincinnati 231 Albert Sabin Way Cincinnati OH 45267-0769 MedicalResearch.com: What are the main findings of the study? Dr. Lindsell: We found that for many patients, the race...
| MedicalResearch.com eInterview with: Dugald Seely ND, MSc, FABNO Founder & Executive Director; Ottawa Integrative Cancer Centre Director; Research & Clinical Epidemiology; Canadian College of Naturopathic Medicine Affiliate Investigator; Ottawa Hospital Research Institute 29 Bayswater Ave Ottawa, ON, K1Y 2E5 www.oicc.ca |
MedicalResearch.com eInterview with Satya Krishna Ramachandran MD FRCA Director, Quality Assurance Department of Anesthesiology University of Michigan MedicalResearch.com: What are the main findings of the study? Answer: Background: A cardiac arrest is a life-threatening condition where the heart has stopped beating. This remains one of the biggest fears of patients undergoing anesthesia and surgery. This is a...
MedicalResearch.com eInterview with: M. Kit Degado, MD, MS
Instructor, Emergency Medicine
Affiliated Faculty, Centers for Health Policy/Primary Care and Outcomes Research
Stanford University School of Medicine
kdelgado@stanford.edu
MedicalResearch.com: What are the main findings of the study?
Dr. Degado: